Overview

• SAIDS reported an adverse analytical finding from a random test, which SARU disclosed on Sunday.
• SARU said Ntlabakanye will not be considered for the upcoming tour to New Zealand so he can focus on his defense.
• The union stated he declared the medication, followed medical due process, and did not seek an unfair advantage.
• Ntlabakanye maintains the substance was prescribed by a specialist early in 2025 and used under the oversight of the team doctor.
• The prop recently featured for the Springboks, including a July Test debut against Italy and a bench role versus Australia at Ellis Park.